
Source externe
Medical Xpress – Actualités Santé
Metastatic pancreatic cancer responds well to treatment with combination of daraxonrasib and chemotherapy
Daraxonrasib combined with chemotherapy caused substantial tumor shrinkage in patients with pancreatic cancer that had spread to other parts of the body, according to new results from a Phase I/II clinical trial.
il y a 4 h· OncologieLire chez la source

Source externe
Medical Xpress – Actualités Santé
Immune aging blueprint offers new clues to fighting cancer
A new study from Monash University has uncovered a genetic blueprint of immune aging, shedding light on why our bodies become less effective at fighting cancer and infections as we grow older. Published in Science Immunology, the preclinical study identified genetic changes that…
il y a 5 h· OncologieLire chez la source

Source externe
Medical Xpress – Actualités Santé
New cancer frontiers: Could COVID vaccines help make treatments more effective?
Recent years have brought extraordinary advances in vaccines and treatments that harness our immune systems.
il y a 6 h· OncologieLire chez la source

Source externe
Medical Xpress – Actualités Santé
MYC inhibitor drug targets cancer cells directly and via the immune system
In a series of experiments, researchers have found that an experimental MYC inhibitor drug not only targets lung cancer cells directly but also makes cancer cells easier for the immune system to target and kill.
il y a 9 h· OncologieLire chez la source

Source externe
Medical Xpress – Actualités Santé
Molecular glues: Unlocking new targets in cancer
The human genome encodes several hundred E3 ligases—the enzymes that decide which proteins a cell destroys. Drug developers have so far harnessed a small number of them. In a new review in Molecular Cell, researchers at Karolinska Institutet and the University of Verona argue…
il y a 11 h· OncologieLire chez la source

Source externe
Medical Xpress – Actualités Santé
Singapore sees 65% decline in cervical cancer mortality rate since 1990, but screening gaps remain
Cervical cancer remains one of the few cancers that can potentially be eliminated through human papillomavirus (HPV) vaccination, regular screening and timely treatment of precancerous changes. Despite the availability of effective prevention and treatment measures, global…
il y a 20 h· OncologieLire chez la source

Source externe
Medical Xpress – Actualités Santé
Cancer cases among trans people could more than double in the next decade, study warns
A study led by Queen Mary University of London has found that the number of new cancer cases each year among transgender and gender-diverse people in England could more than double over the next decade.
hier· OncologieLire chez la source

Source externe
Medical Xpress – Actualités Santé
Newly discovered mechanism may help ovarian cancer cells silence tumor-suppressor genes
Researchers at Umeå University have discovered how chemical marks on RNA control a DNA methylation enzyme and contribute to the silencing of tumor-suppressor genes in ovarian cancer cells. The findings provide new insights into the disease and may, in the long term, contribute…
hier· OncologieLire chez la source

Source externe
Medical Xpress – Actualités Santé
Experimental GLS-1 inhibitor demonstrates antitumor activity in advanced treatment-resistant ovarian cancer
Combining the experimental therapy IACS-6274 with targeted therapy bevacizumab and paclitaxel chemotherapy showed promising antitumor activity in a Phase I trial of patients with advanced platinum-resistant ovarian cancer, according to new results presented by researchers from…
hier· OncologieLire chez la source

Source externe
Medical Xpress – Actualités Santé
Predictive biomarker for liver cancer associated with survival outcomes, effectiveness of systemic therapy
Liver cancer was the sixth most common cancer and the third leading cause of cancer-related deaths worldwide in 2022, with hepatocellular carcinoma (HCC) as the most common histological subtype, accounting for approximately 90% of liver cancers. Despite this, biomarkers that…
hier· OncologieLire chez la source

Source externe
Medical Xpress – Actualités Santé
Experimental antibody-drug conjugate shows promising initial activity in head and neck cancers
The investigational antibody-drug conjugate (ADC) micvotabart pelidotin (MICVO, PYX-201) demonstrated promising antitumor activity and a manageable safety profile in a Phase I trial presented at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics by…
hier· OncologieLire chez la source

Source externe
Medical Xpress – Actualités Santé
Researchers find two understudied 'forever chemicals' raise liver cancer risk
A first-of-its-kind USC study links two little-studied "forever chemicals" to liver cancer, with the greatest risk in those already genetically susceptible to fatty liver disease. The study, published in Environmental Health Perspectives, finds that two per- and polyfluoroalkyl…
hier· OncologieLire chez la source
Source externe
The BMJ – Actualités & Recherches
Brown fat . . . and other stories
Corticosteroids before cancer surgeryWould suppressing the inflammatory response to major surgery improve recovery? Probably not, according to a double blind trial of 1210 patients undergoing surgery for gastrointestinal cancer who received a single dose of either…
hier· OncologieLire chez la source

Source externe
Medical Xpress – Actualités Santé
Analysis of over 69,000 younger patients questions one-size-fits-all cutoff for colorectal cancer stool test
A new study led by experts at the University of Nottingham has provided new insight into how a commonly used test for colorectal cancer performs in people under 50.
hier· OncologieLire chez la source

Source externe
Medical Xpress – Actualités Santé
Morphea linked to higher risk for cancer
Morphea is associated with excess cancer incidence, according to a study published online Nov. 11 in JAMA Dermatology.
il y a 2 jours· OncologieLire chez la source

Source externe
Medical Xpress – Actualités Santé
How cancer cells protect themselves from a toxin they produce
Cancer cells must protect themselves from the harmful substances they produce as they grow. Now, researchers have identified how they neutralize one of these substances, formaldehyde, while keeping another defense against cell death intact. The findings suggest a way to attack…
il y a 2 jours· OncologieLire chez la source

Source externe
Medical Xpress – Actualités Santé
Medicare boost needed for Australia's 1.6 million cancer survivors
More than 1.6 million Australians living with and beyond cancer could benefit from proposed Medicare reforms to increase subsidized allied health visits, a move backed by new Flinders University–led research.
il y a 2 jours· OncologieLire chez la source

Source externe
Medical Xpress – Actualités Santé
AI may help spot early signs of lung cancer in the blood
In a blue-and-white van outside Asda last June, 68-year-old Eddie, a retired fishmonger from Fallowfield, near Manchester, received life-changing news.
il y a 3 jours· OncologieLire chez la source
Page 1 sur 5
Plus anciennes →